Kao Corp. Stock
€33.08
Your prediction
Kao Corp. Stock
Pros and Cons of Kao Corp. in the next few years
Pros
Cons
Performance of Kao Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kao Corp. | -1.650% | 6.026% | 1.379% | -18.321% | -3.472% | -1.840% | -36.628% |
| Unicharm Corp. | -5.380% | 5.932% | 1.215% | - | 2.881% | - | - |
| Pola Orbis Holdings Inc. | -0.750% | 0.758% | -1.481% | -16.352% | -4.317% | -51.103% | -69.773% |
| Kose Corp | 0.000% | 2.174% | -8.442% | -20.787% | 0.714% | -70.159% | -78.797% |
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4


